Literature DB >> 16546082

Natural selection drives extremely rapid evolution in antiviral RNAi genes.

Darren J Obbard1, Francis M Jiggins, Daniel L Halligan, Tom J Little.   

Abstract

RNA interference (RNAi) is perhaps best known as a laboratory tool. However, RNAi-related pathways represent an antiviral component of innate immunity in both plants and animals. Since viruses can protect themselves by suppressing RNAi, interaction between RNA viruses and host RNAi may represent an ancient coevolutionary "arms race." This could lead to strong directional selection on RNAi genes, but to date their evolution has not been studied. By comparing DNA sequences from different species of Drosophila, we show that the rate of amino acid evolution is substantially elevated in genes related to antiviral RNAi function (Dcr2, R2D2, and Ago2). They are among the fastest evolving 3% of all Drosophila genes; they evolve significantly faster than other components of innate immunity and faster than paralogous genes that mediate "housekeeping" functions. Based on DNA polymorphism data from three species of Drosophila, McDonald-Kreitman tests showed that this rapid evolution is due to strong positive selection. Furthermore, Dcr2 and Ago2 display reduced genetic diversity, indicative of a recent selective sweep in both genes. Together, these data show rapid adaptive evolution of the antiviral RNAi pathway in Drosophila. This is a signature of host-pathogen arms races and implies that the ancient battle between RNA viruses and host antiviral RNAi genes is active and significant in shaping RNAi function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546082     DOI: 10.1016/j.cub.2006.01.065

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  140 in total

1.  Genomic variation in natural populations of Drosophila melanogaster.

Authors:  Charles H Langley; Kristian Stevens; Charis Cardeno; Yuh Chwen G Lee; Daniel R Schrider; John E Pool; Sasha A Langley; Charlyn Suarez; Russell B Corbett-Detig; Bryan Kolaczkowski; Shu Fang; Phillip M Nista; Alisha K Holloway; Andrew D Kern; Colin N Dewey; Yun S Song; Matthew W Hahn; David J Begun
Journal:  Genetics       Date:  2012-06-05       Impact factor: 4.562

Review 2.  Arbovirus-mosquito interactions: RNAi pathway.

Authors:  Ken E Olson; Carol D Blair
Journal:  Curr Opin Virol       Date:  2015-12-06       Impact factor: 7.090

Review 3.  On the origin and functions of RNA-mediated silencing: from protists to man.

Authors:  Heriberto Cerutti; J Armando Casas-Mollano
Journal:  Curr Genet       Date:  2006-05-12       Impact factor: 3.886

4.  Drosophila Genomes by the Baker's Dozen. Preface.

Authors:  Michael Ashburner
Journal:  Genetics       Date:  2007-11       Impact factor: 4.562

Review 5.  Antiviral immunity directed by small RNAs.

Authors:  Shou-Wei Ding; Olivier Voinnet
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

6.  Introduction. Ecological immunology.

Authors:  Hinrich Schulenburg; Joachim Kurtz; Yannick Moret; Michael T Siva-Jothy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-12       Impact factor: 6.237

Review 7.  Interspecies regulation of microRNAs and their targets.

Authors:  Misook Ha; Mingxiong Pang; Vikram Agarwal; Z Jeffrey Chen
Journal:  Biochim Biophys Acta       Date:  2008-03-25

Review 8.  Antiviral Immunity and Virus-Mediated Antagonism in Disease Vector Mosquitoes.

Authors:  Glady Hazitha Samuel; Zach N Adelman; Kevin M Myles
Journal:  Trends Microbiol       Date:  2018-01-31       Impact factor: 17.079

Review 9.  Towards the elements of successful insect RNAi.

Authors:  Jeffrey G Scott; Kristin Michel; Lyric C Bartholomay; Blair D Siegfried; Wayne B Hunter; Guy Smagghe; Kun Yan Zhu; Angela E Douglas
Journal:  J Insect Physiol       Date:  2013-09-13       Impact factor: 2.354

10.  Evolutionary rate analyses of orthologs and paralogs from 12 Drosophila genomes.

Authors:  Andreas Heger; Chris P Ponting
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.